Polar Capital Global Healthcare Trust PLC (LSE:PCGH) shares fell to 446.00p, down 4.00p, or 0.89%, according to the market data provided, as sentiment toward global healthcare equities softened.
Oxford Biomedica PLC (LSE:OXB) shares fell to 484.00p, down 3.50p, or 0.72%, according to the market data provided, a modest decline for the gene and cell therapyManufacturingspecialist.
EDX Medical Group develops diagnostic products and services intended to improve disease detection and support personalised treatment. Its principal areas include cancer, cardiovascular disease, infectious disease and broader health screening. The recent share-price rise appears to reflect renewed interest following product launches, NHS deployment …
Spire Healthcare Group PLC (LSE:SPI)shares declined0.43%, a relatively small movement that does not necessarily indicate a significant deterioration in the company's fundamentals.
Genflow Biosciences Plc is an AIM-listed biotechnology company developing gene therapies targeting age-related and metabolic diseases, built around licensed longevity-gene technology. The shares advanced strongly in the latest session, a move consistent with renewed investor interest in early-stage biotech names as sentiment toward the …
OptiBiotix Health plc develops microbiome-based ingredients and consumer products focused on weight management, gut health and healthier sugar alternatives. Its main technologies include SlimBiome, WellBiome and SweetBiotix. The stock’s recent rise reflects improved order momentum, stronger margins and optimism that years of product development …
Abingdon Health plc is an international contract-development, manufacturing and regulatory-services provider specializing in rapid diagnostic tests and wider medical technology. Its integrated platform supports customers from product concept and assay development through regulatory approval and commercial production. The stock’s recent rise reflects stronger trading, …
Hostelworld Group plc operates a technology-led travel platform connecting budget-conscious travelers with hostels and other accommodation providers. The company is evolving from a specialist online booking agent into a broader social travel network incorporating traveler matching, event discovery and paid social access. The stock’s …
Allergy Therapeutics plc is a commercial biotechnology company focused on diagnosing and treating allergic conditions through immunotherapy. Its portfolio includes treatments for pollen, venom and other allergies, alongside a development pipeline targeting significant unmet needs such as peanut allergy. The stock’s recent improvement reflects …
Coiled Therapeutics develops small-molecule treatments designed to exploit specific biological dependencies in aggressive cancers. Its lead programme, AO-252, is a brain-penetrant oral inhibitor of TACC3, a protein involved in cancer-cell division, DNA-damage repair and survival. The stock’s recent rise appears to reflect growing confidence …